HR 124 · in committee · niche
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
- healthcare
What this bill does
- States can receive federal Medicaid funding to cover half the cost of educating people with sickle cell disease about renal medullary carcinoma risk.
- People with sickle cell disease and state Medicaid programs are affected by this awareness initiative.
- The federal government will reimburse states for 50% of education program costs through Medicaid.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How might a 50% federal cost-share affect states' willingness to implement renal medullary carcinoma awareness programs for sickle cell disease patients?
- 02
What evidence supports the claim that targeted education about this cancer risk will meaningfully improve health outcomes for people with sickle cell disease?
- 03
Should the federal government fund disease-specific awareness campaigns through Medicaid, or are there alternative approaches to reach at-risk populations?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · D-TX-9
Al Green
Citizen cosponsors
0
In Congress
0/ 435
House Reps cosponsoring
Introduced 2025-01-03
Legislative timeline
2025-01-03 · house · IntroReferral
Referred to the House Committee on Energy and Commerce.
2025-01-03 · IntroReferral
Introduced in House
2025-01-03 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.